Author: Tom Wilemon
Sep. 17, 2020—Chic Awearness, in collaboration with the Vanderbilt-Ingram Cancer Center, will host a virtual event on Sept. 24 focusing on ovarian cancer research and its impact during COVID-19.
Aug. 27, 2020—Vanderbilt-Ingram Cancer Center at Wilson County is slated to open Aug. 31 with a full array of highly specialized services, including diagnostic assessments, medical oncology and radiation oncology.
Aug. 26, 2020—Sam Chang, MD, MBA, has been named chief surgical officer at Vanderbilt-Ingram Cancer Center (VICC), a new leadership position responsible for advancing excellence in surgical care in cancer patients, expanding service locations, maximizing resource efficiencies and maintaining high-quality standards among other duties.
Aug. 13, 2020—Patients with ALK-positive non-small cell lung cancer treated with ensartinib fared better and lived longer than those who received crizotinib, according to results of a phase 3 study.
Aug. 6, 2020—Non-white Americans, especially Asian Americans, are at disproportionately higher risk for gastric cancer compared to non-Hispanic white Americans. A new study breaks down this risk according to specific ethnicities and locations within the stomach.
Aug. 6, 2020—Nancy Davis, MD, has been named senior medical director for VICC Cancer Care Network and Strategy, a new leadership position at Vanderbilt-Ingram Cancer Center responsible for expanding cancer clinics within and beyond the Middle Tennessee catchment area.
Aug. 6, 2020—Laura Goff, MD, MSCI, associate professor of Medicine, has been named the executive medical director for the Vanderbilt-Ingram Cancer Center (VICC) Cancer Patient Care Center.
Jul. 30, 2020—Wade Iams, MD, MSCI, assistant professor of Medicine, is the recipient of a National Comprehensive Cancer Network Foundation Young Investigator Award.
Jul. 22, 2020—Newly released data on treatment outcomes of people with cancer diagnosed with COVID-19 reveal a racial disparity in access to Remdesivir, an antiviral drug that has been shown to shorten hospital stays, and increased mortality associated with dexamethasone, a steroid that has had the opposite effect in the general patient population.
Jul. 16, 2020—After serving 16 years as associate director for Research Education at Vanderbilt-Ingram Cancer Center (VICC), Ann Richmond, PhD, Ingram Professor of Cancer Research, is stepping down from the leadership post.
Friedman named associate director for Community Science and Health Outcomes at Vanderbilt-Ingram Cancer Center
Jul. 2, 2020—Debra Friedman, MD, MS, E. Bronson Ingram Chair of Pediatric Oncology, is expanding her leadership role in improving cancer outcomes both within and beyond the Vanderbilt-Ingram Cancer Center (VICC) catchment area. She has been named associate director of Community Science and Health Outcomes.
Jun. 24, 2020—People with inoperable anal cancer treated with carboplatin-paclitaxel had fewer complications and lived longer than those who received another chemotherapy that has been more often administered.